Skip to main content
Signal8
Decheng Capital China Life Sciences USD Fund III, L.P. profile photo

Decheng Capital China Life Sciences USD Fund III, L.P.

CIK: 0001736814

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)63 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BeyondSpring Inc. logo
BYSI

BeyondSpring Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (63 total)

  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 17, 2025
    Sale(S)
    Indirect
    45.5K shares at avg. $1.76$80K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 16, 2025
    Sale(S)
    Indirect
    85.8K shares at avg. $1.72$148K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 15, 2025
    Sale(S)
    Indirect
    18K shares at avg. $1.65$30K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 14, 2025
    Sale(S)
    Indirect
    28.5K shares at avg. $1.65$47K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 13, 2025
    Sale(S)
    Indirect
    107.4K shares at avg. $1.70$183K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 10, 2025
    Sale(S)
    Indirect
    2.4K shares at avg. $1.77$4K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 9, 2025
    Sale(S)
    Indirect
    4K shares at avg. $1.81$7K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 8, 2025
    Sale(S)
    Indirect
    7.5K shares at avg. $1.77$13K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 7, 2025
    Sale(S)
    Indirect
    2.1K shares at avg. $1.79$4K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 6, 2025
    Sale(S)
    Indirect
    17.5K shares at avg. $1.78$31K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 3, 2025
    Sale(S)
    Indirect
    600 shares at avg. $1.76$1K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 2, 2025
    Sale(S)
    Indirect
    600 shares at avg. $1.73$1K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Oct 1, 2025
    Sale(S)
    Indirect
    2.6K shares at avg. $1.80$5K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 30, 2025
    Sale(S)
    Indirect
    4.5K shares at avg. $1.81$8K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 29, 2025
    Sale(S)
    Indirect
    500 shares at avg. $1.75$875
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 26, 2025
    Sale(S)
    Indirect
    600 shares at avg. $1.68$1K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 25, 2025
    Sale(S)
    Indirect
    700 shares at avg. $1.66$1K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 24, 2025
    Sale(S)
    Indirect
    2.3K shares at avg. $1.68$4K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 23, 2025
    Sale(S)
    Indirect
    4.1K shares at avg. $1.72$7K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 22, 2025
    Sale(S)
    Indirect
    5.4K shares at avg. $1.83$10K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 19, 2025
    Sale(S)
    Indirect
    3.7K shares at avg. $1.79$7K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 18, 2025
    Sale(S)
    Indirect
    5.3K shares at avg. $1.74$9K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 17, 2025
    Sale(S)
    Indirect
    2.3K shares at avg. $1.83$4K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 16, 2025
    Sale(S)
    Indirect
    840 shares at avg. $1.88$2K
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Sep 15, 2025
    Sale(S)
    Indirect
    2.6K shares at avg. $1.84$5K

1-25 of 63

About Decheng Capital China Life Sciences USD Fund III, L.P.

Decheng Capital China Life Sciences USD Fund III, L.P. (SEC CIK 0001736814) files insider reports with the SEC as 10% Owner of BeyondSpring Inc. (BYSI).

Signal8 holds 18 ownership filings by Decheng Capital China Life Sciences USD Fund III, L.P. (1 Form 3, 17 Form 4), filed between Aug 11, 2025 and Oct 20, 2025. Those filings report 63 transactions, from Jun 17, 2025 to Oct 17, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Decheng Capital China Life Sciences USD Fund III, L.P.'s filings is in MENLO PARK, CA.

Recent filings by Decheng Capital China Life Sciences USD Fund III, L.P.

  • Oct 17, 2025: Open-market sale of BYSI shares (Form 4, code S).
  • Oct 16, 2025: Open-market sale of BYSI shares (Form 4, code S).
  • Oct 15, 2025: Open-market sale of BYSI shares (Form 4, code S).
  • Oct 14, 2025: Open-market sale of BYSI shares (Form 4, code S).
  • Oct 13, 2025: Open-market sale of BYSI shares (Form 4, code S).

Other insiders filing for BeyondSpring Inc. (BYSI)

How to read Form 4 transaction codes